CURN DCF Valuation - Kinarus Therapeutics Holding AG

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 23.5 CHF

Market Cap: CHf121.3m

	Kinarus Therapeutics Holding AG SIX:CURN	CH
	United Plantations Bhd OTC:UPBMF	MY
R	Ryder System Inc XBER:RYD	US
	MP Materials Corp NYSE:MP	US
P	Pacira Biosciences Inc XBER:82P	US
D	Daimler Truck Holding AG DUS:DTG	DE
T	Telix Pharmaceuticals Ltd OTC:TLPPF	AU

CURN's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue CURN Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

SIX • CHF

KNRS

Join 349,900+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.